A detailed history of Cypress Capital Management LLC (Wy) transactions in Eli Lilly & CO stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 82 shares of LLY stock, worth $63,846. This represents 0.08% of its overall portfolio holdings.

Number of Shares
82
Previous 82 -0.0%
Holding current value
$63,846
Previous $74,000 2.7%
% of portfolio
0.08%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $2,174 - $2,727
-3 Reduced 3.53%
82 $74,000
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $7,877 - $9,286
-15 Reduced 15.0%
85 $49,000
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $20,904 - $24,545
75 Added 300.0%
100 $32,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $4,108 - $5,318
25 New
25 $5,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $2,135 - $2,323
-20 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$105.9 - $118.64 $2,118 - $2,372
20 New
20 $2,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.